ATRS Antares Pharma Inc

Antares Pharma Inc is a specialty pharmaceutical company. It is engaged in developing and commercializing self-administered parenteral pharmaceutical products and technologies including novel, pressure-assisted injectors.

$3.32  +0.06 (1.84%)
As of 12/07/2021 12:03:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  06/11/2012
Outstanding shares:  170,042,479
Average volume:  663,928
Market cap:   $535,633,809
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    036642106
ISIN:        US0366421065
Sedol:      2383163
Valuation   (See tab for details)
PE ratio:   8.53
PB ratio:   3.94
PS ratio:   2.99
Return on equity:   47.77%
Net income %:   37.50%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy